This site is intended for healthcare professionals

Final results from phase III CASPIAN study of Imfinzi shows meaningful overall survival benefit to treat small cell lung cancer. AstraZeneca

Read time: 1 mins
Published:18th Mar 2020
Condition: Small Cell Lung Cancer
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest